# ACROBiosystems

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/acrobiosystems
Canonical HTML page: https://getbiobrief.com/entity/acrobiosystems

## Timeline

- **2026-07-14**: ACROBiosystems announces PMDA confirmation for GMP-grade IL-15 — Company officially receives Material Suitability Confirmation (Certificate No. 薬機審長発第47号) for its IL-15 protein, enabling streamlined regulatory evaluation in Japan.

## Recent coverage (1 stories)

### ACROBiosystems PMDA Certificate No. 47 for IL-15 Streamlines Japan Cell & Gene Therapy Trials
2026-07-27 09:23:11 · Sentiment: Bullish · Impact: 6/10 · Sources: 2

The PMDA confirmation validates ACROBiosystems' quality system and allows cell therapy developers to expedite raw material review, potentially accelerating clinical trial applications in Japan. This strengthens the supply chain for regenerative medicine raw materials.
Full story: https://getbiobrief.com/story/acrobiosystems-il15-pmda-certification

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.